Annika Dejmek (Former)
1 – 20 of 32
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Comparison of immunohistochemical mesothelial biomarkers in paired biopsies and effusion cytology cell blocks from pleural mesothelioma
(
- Contribution to journal › Article
- 2022
-
Mark
PD‐L1 Expression in Non‐Small Cell Lung Cancer Specimens : Association with Clinicopathological Factors and Molecular Alterations
(
- Contribution to journal › Article
- 2021
-
Mark
PD-L1 Testing in Cytological Non-Small Cell Lung Cancer Specimens : A Comparison with Biopsies and Review of the Literature
(
- Contribution to journal › Article
-
Mark
Factors influencing concordance of pd-l1 expression between biopsies and cytological specimens in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Higher concordance of PD-L1 expression between biopsies and effusions in epithelioid than in nonepithelioid pleural mesothelioma
(
- Contribution to journal › Article
- 2019
-
Mark
Immune effector monocyte–neutrophil cooperation induced by the primary tumor prevents metastatic progression of breast cancer
2019) In Proceedings of the National Academy of Sciences of the United States of America 116(43). p.21704-21714(
- Contribution to journal › Article
- 2017
-
Mark
Determination of PD-L1 expression in effusions from mesothelioma by immuno-cytochemical staining
(
- Contribution to journal › Article
- 2016
-
Mark
Combined assessment of polymorphisms in the LHCGR and FSHR genes predict chance of pregnancy after in vitro fertilization.
(
- Contribution to journal › Article
- 2015
-
Mark
Guidelines for the Cytopathologic Diagnosis of Epithelioid and Mixed-Type Malignant Mesothelioma: a secondary publication.
(
- Contribution to journal › Scientific review
-
Mark
Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma: Complementary Statement from the International Mesothelioma Interest Group, Also Endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology.
(
- Contribution to journal › Article
-
Mark
Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology.
(
- Contribution to journal › Scientific review
- 2014
-
Mark
Telomerase activity analyzed with trap in situ provides additional information in effusions remaining equivocal after immunocytochemistry and hyaluronan analysis.
(
- Contribution to journal › Article
- 2013
-
Mark
Preparation of DNA from cytological material: Effects of Fixation, Staining, and Mounting Medium on DNA Yield and Quality.
(
- Contribution to journal › Article
-
Mark
Liquid-based cytology using cytorich Red/Tripath is diagnostically equivalent to conventional smears for bronchial washings and brushings and reduces the cost.
(
- Contribution to journal › Article
- 2010
-
Mark
Comparison of Liquid-Based Cytology and Conventional Filter Preparations in Urine: A Possible Serious Pitfall
(
- Contribution to journal › Letter
-
Mark
Podoplanin Is a Useful Marker for Identifying Mesothelioma in Malignant Effusions
(
- Contribution to journal › Article
-
Mark
Possibility of Mixed Progenitor Cells in Sea Star Arm Regeneration
2010) In Journal of Experimental Zoology Part B: Molecular and Developmental Evolution 314B(6). p.457-468(
- Contribution to journal › Article
- 2008
-
Mark
Telomerase activity in effusions: a comparison between telomere repeat amplification protocol in situ and conventional telomere repeat amplification protocol assay.
(
- Contribution to journal › Article
-
Mark
CK5/6 in effusions: no difference between mesothelioma and pulmonary and nonpulmonary adenocarcinoma.
(
- Contribution to journal › Article
- 2007
-
Mark
Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions
(
- Contribution to journal › Article